Cair Health Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cair Health Inc. - overview
Established
2023
Location
Palo Alto, CA, US
Primary Industry
Software
About
Based in California, US, and founded in 2023 by Ishan Balakrishnan and Shehbaz Virk, Cair Health Inc. , a. k. a.
Cair Health operates as a software company that focuses on developing an artificial intelligence (AI)-powered software solution with prediction, automation, and intelligence capabilities for revenue and insurance workflows. In September 2023, Cair Health raised venture funding from TRAC. The company provides an AI-powered software platform to streamline and optimize medical insurance workflows for healthcare providers. The platform leverages advanced machine learning models to predict and flag revenue challenges before they occur, monitoring claims.
The platform’s custom large language models (LLMs) automate claim issue resolution, providing one-click optimization. Additionally, the platform’s conversational co-pilots offer real-time insights into payer policies, negotiated rates, and insurance contracts.
Current Investors
TRAC, Foundation Capital, Y Combinator
Primary Industry
Software
Sub Industries
Accounting/Finance Software, Analytics & Performance Software
Website
www.cairhealth.com
Verticals
Artificial Intelligence, Cloud Computing, FinTech, InsureTech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.